3593 — Hogy Medical Co Income Statement
0.000.00%
- ¥113bn
- ¥104bn
- ¥39bn
- 58
- 27
- 77
- 57
Annual income statement for Hogy Medical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 36,504 | 36,778 | 38,981 | 39,100 | 39,138 |
| Cost of Revenue | |||||
| Gross Profit | 15,327 | 15,417 | 15,740 | 13,063 | 12,621 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 30,899 | 30,643 | 32,811 | 35,141 | 37,142 |
| Operating Profit | 5,605 | 6,135 | 6,170 | 3,959 | 1,996 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 6,989 | 6,286 | 6,189 | 4,075 | 2,934 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4,929 | 4,335 | 4,285 | 2,793 | 1,521 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 4,959 | 4,370 | 4,316 | 2,804 | 1,521 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4,959 | 4,370 | 4,316 | 2,804 | 1,520 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 165 | 153 | 191 | 120 | 110 |
| Dividends per Share |